Funding Received
$26 Million in 2 Rounds from 3 Investors
Most Recent Funding
$6 Million Series C on January 3, 2013
Founded:
2005
Headquarters:
Palo Alto, CA
Description:
Carbylan BioSurgery develops and markets advanced biomaterial-based therapies to treat aches and pains associated with osteoarthritis.
Categories:
Health Care
Website:
http://www.carbylan.com

Detailed Description

Update

Carbylan was founded in 2005 to develop and market medical devices and device/drug combination products based on chemically engineered polymers of hyaluronic acid, a well known polysaccharide widely present in the human body.

Its initial market focus is therapeutic medical devices for rhinosinusitis and osteoarthritis. Carbylan’s proprietary technology enables delivery of biomaterial-based medical devices as injectable liquids that self-polymerize inside the body to form therapeutic implants that covalently bind to tissues at the target delivery site.

Past Team (2)

Update

Funding Rounds (2) - $26M

Update

Board Members and Advisors (1)

Update

Investors (3)

Update
  • Bb3d6fbd0e442789b59061f392f8ad0d

    InterWest Partners

    InterWest invests an average of about $7 - 15 million over the span of their involvement with...
  • Ffd282ddd28c8fabdd3520a4e2cb89d5

    Vivo Ventures

    life-science investments
  • 712e099ef0f0e07efb25e9ce6cdd10d4

    Alta Partners

    Alta Partners is a leading venture capital firm in life sciences, funding over 130 companies in...

Offices/Locations (1)

Update
  • Office

    3181 Porter Drive

    Palo Alto, CA 94304

    USA